presentation on pharma cue ti cal industry

Upload: 9dip

Post on 07-Apr-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/3/2019 Presentation on Pharma Cue Ti Cal Industry

    1/16

    Indian Pharmaceutical Industry

    FINANCIAL ANANLYSES

    PREPARED BY:

    ASHA PATELROLL NO. 28

  • 8/3/2019 Presentation on Pharma Cue Ti Cal Industry

    2/16

    INTRODUCTION

    A pharmaceutical company, or drug company, is acommercial business whose focus is to research,develop, market and/or distribute drugs, most commonly

    in the context of healthcare. They can deal in genericand/or brand medications. They are subject to a varietyof laws and regulations regarding the patenting, testingand marketing of drugs. From its beginnings at the startof the 19th Century, the pharmaceutical industry is now

    one of the most successful and influential, attracting bothpraise and controversy.

  • 8/3/2019 Presentation on Pharma Cue Ti Cal Industry

    3/16

    Presentation Structure

    Indian Pharmaceutical Evolution

    India Advantage

    Financial analyses

  • 8/3/2019 Presentation on Pharma Cue Ti Cal Industry

    4/16

    Indian Pharmaceutical Evolution

    Phase IIGovernment Control

    Indian Patent Act 1970

    Drug prices capped

    Local companies beginto make an impact

    Phase III

    Development Phase

    Process

    development

    Production

    infrastructure

    creation

    Export initiatives

    Phase IV

    Growth Phase

    Rapid expansion of

    domestic market

    International marketdevelopment

    Research orientation

    Phase V

    Innovation and Research

    New IP law

    Discovery Research

    Convergence

    1970 1980 1990 2000 2010

    Phase I

    Early Years

    Market sharedomination byforeign companies

    Relative absenceof organizedIndian companies

  • 8/3/2019 Presentation on Pharma Cue Ti Cal Industry

    5/16

    India Advantage

    Large skill base Experts in process chemistry

    Long history of reverse engineering

    Unmatched cost competitiveness Lower cost of infrastructure and skilled manpower

    Vertical integration

  • 8/3/2019 Presentation on Pharma Cue Ti Cal Industry

    6/16

    India Advantage

    Strong local industry Growing expertise with international regulatory compliance

    High quality manufacturing with abundant capacities

    Speed Very strong entrepreneurial spirit

    Hungry for growth and recognition

    Quick learners and fast movers

    Availability of capital Stock market has seen unprecedented growth in the last decade

    Continues to be bullish on the pharma industry

  • 8/3/2019 Presentation on Pharma Cue Ti Cal Industry

    7/16

    Financial analyses

    BALANCE SHEET

    SOURCESDec 2004

    Rs in crore

    Dec 2005

    In crore

    Dec 2006

    In crore

    Capital 1,858.91 1,862.21 1,863.43

    Reserves 23,218.49 23,405.03 23,986.48

    Deferred Tax Liability 1,908.47 1,899.27 1,636.03

    Minority Interest 208.77 168.69 343.22

    LTL 8,527.30 20,042.62 39,556.19

    CL 18,389.06 15,007.92 17,596.57

    Total 54111 62,385.74 84,981.92

    Fixed Assets 15,294.13 20,591.41 38,953.34

    Investments 183.77 171.72 362.35

    Deferred Tax Asset 836.66 2,698.34 981.16

    Capital(WIP) 2,875.54 5,595.49 3,580.98

    CA 34,920.90 33,328.78 41,104.09

    Total 54111 62385.74 84981.92

  • 8/3/2019 Presentation on Pharma Cue Ti Cal Industry

    8/16

    Ratio analyses Liquidity Ratios:

    Liquidity refers to ability of firm to meet it shortterm requirements. Here, short term meansrequirements which are to be meet in a period of 1year. Liquidity is generally dependent on twothings current assets and current liabilities.

    Working capital ratio:

    Working capital refers to the cash a business requires

    for day-to-day operations

    2004 2005 2006

    CA (in Rs mn) 18283.77 23529 37045.39

    CL 4410.227 6103.3 7363.989

    Working Capital 13873.54 17425.7 29681.4

  • 8/3/2019 Presentation on Pharma Cue Ti Cal Industry

    9/16

    Current ratio

    An indication of a industry's ability to meet short-term debt

    obligations; the higher the ratio, the more liquid the company is.Current ratio is equal to current assets divided by currentliabilities. If the current assets of a company are more than twicethe current liabilities, then that company is generally consideredto have good short-term financial strength.

    Current ratio = Current assets / current liabilities

    liquidity ratio

    As current ratio includes some items which are not veryliquid, so liquid ratio is more accurate measure of liquidity

    of firm

    Liquid ratio = Current assets inventory/

    Current liabilities

  • 8/3/2019 Presentation on Pharma Cue Ti Cal Industry

    10/16

    Cash ratio

    As liquid ratio contains debtors, so it does not gives a clear

    picture of cash and near cash items. So we calculate cash ratio

    to know about the liquidity of firm for very short terms.

    Years 2004 2005 2006

    CA (in Rscrore) 34,920.90 33,328.78 41,104.09

    Inventory 14350.94 13624.02 16115.52

    Debtors 11356.67 11403.52 15716.33

    CL 18,389.06 15,007.92 17,596.57

    Current ratio 1.899004 2.220746 2.335915

    Liquid Ratio 1.118598 1.312957 1.420082

    Cash Ratio 0.50102 0.553124 0.526935

  • 8/3/2019 Presentation on Pharma Cue Ti Cal Industry

    11/16

    Comparison

  • 8/3/2019 Presentation on Pharma Cue Ti Cal Industry

    12/16

    Interpretation The industrys current ratio for period of three years is somewhat

    equal to 2 for 2005 it is less than 2 but it can be almost equivalent totwo). So industry has very sound liquidity position. It signifies thatindustry can easily meet its short term obligations. Also the liquidratio is equal to one that is a equivalent to its ideal value.

    The cash ratio is 0.5 it implies that companies has cash or near cashitems which is equivalent to 50% of current liabilities.

    As current ratio is double of Liquid ratio, and four times of cashratio, it shows that debtors, inventory and cash forms significant part ofthe current assets. And industry has properly distributed its current

    assets.

    The company is also able to maintain the liquidity of companythroughout the period of three years. As the values for ratios remainsame for the industry even value of current assets has over the period.

  • 8/3/2019 Presentation on Pharma Cue Ti Cal Industry

    13/16

    EPS(Earnings Per Share):

    EPS = PAT/ No. Of Shares

    It denotes the profit earned by the money of each share

    holders.

    Particulars Dec 2004 Dec 2005 Dec 2006

    EPS 35.23 4.42 8.62

    From the above table it is quite cleat that EPS is decreasing

    for industry. But the reason for low EPS is not low profit earned

    by the industry but it is due the fact the industry raised more

    equity capital in this year.

  • 8/3/2019 Presentation on Pharma Cue Ti Cal Industry

    14/16

    Interest Coverage ratio: A ratio used to determine how easily a industry can

    pay interest on outstanding debt.

    The lower the ratio, the more the industry is

    burdened by debt expense

    Particulars Dec 2004 Dec 2005 Dec 2006

    PBIT 9599 2282.86 7546.66

    Interest 334.88 671.16 1036.32

    industry is covering its interest expenses very well.

  • 8/3/2019 Presentation on Pharma Cue Ti Cal Industry

    15/16

    Closing Comment

    India is an acquired taste

    Give it some time & it will grow on you

  • 8/3/2019 Presentation on Pharma Cue Ti Cal Industry

    16/16

    Thank you!